You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 129 No. 6, June 1972 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  INTERFACE
 •Online Features
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (85)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Diphenylhydantoin Effects on Human Lymphocytes in Vitro and in Vivo

An Hypothesis to Explain Some Drug Reactions

Archie A. MacKinney, MD; Harold E. Booker, MD

Arch Intern Med. 1972;129(6):988-992.


Abstract



We investigated the problem of idiosyncratic reactions to diphenylhydantoin sodium (Dilantin) using tissue culture techniques and measurement of absolute peripheral lymphocyte numbers and immunoglobulin serum values. Diphenylhydantoin was used as antigen to stimulate peripheral blood lymphocyte cultures of 8 patients with serious reactions to the drug, 23 patients without reactions, and 8 normal controls. Diphenylhydantoin inhibited thymidine incorporation in cultures of patients with serious reactions to diphenylhydantoin. Patients who were taking diphenylhydantoin without reaction had lower proportions of DNA synthesizing cells in seven-day unstimulated cultures than normal controls. Sixty-six patients receiving the drug were shown to have negative correlation between serum diphenylhydantoin level and the absolute peripheral blood lymphocyte numbers. Immunoglobulin quantitation of matched groups of 20 patients showed decrease in IgG levels in serum of those receiving diphenylhydantoin. An hypothesis relating these data to the development of lymphoma and autoimmune phenomena is offered.



Author Affiliations



Madison, Wis

From the Veterans Administration Hospital, Department of Medicine (Dr. MacKinney) and Epilepsy Center, Department of Neurology, University of Wisconsin School of Medicine (Dr. Booker), Madison.


Footnotes



Received for publication July 30, 1971; accepted Dec 19.

Reprint requests to Veterans Administration Hospital, 2500 Overlook Terrace, Madison, Wis 53705 (Dr. MacKinney).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phenytoin-Induced IgA Depression
Ruff et al.
Arch Pediatr Adolesc Med 1987;141:858-861.
ABSTRACT  

Assessment of Polymorphonucleate Leucocyte Functions in Adult Epileptic Patients Undergoing Long-term Phenytoin Treatment
Ricevuti et al.
Hum Exp Toxicol 1986;5:237-241.
ABSTRACT  

Erythroderma, Hypogammaglobulinemia, and T-Cell Lymphocytosis: Occurrence Following Therapy With Phenytoin
Lillie et al.
Arch Dermatol 1983;119:415-418.
ABSTRACT  

Phenytoin and Formation of T Lymphocyte Rosettes
Neilan and Leppik
Arch Neurol 1980;37:580-581.
ABSTRACT  

Phenytoin-Induced Pseudolymphoma Syndrome: An Immunologic Study
Charlesworth
Arch Dermatol 1977;113:477-480.
ABSTRACT  

Drug-Induced IgA Deficiency in Epileptic Patients
Aarli
Arch Neurol 1976;33:296-299.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.